Published 11 days ago • loading... • Updated 11 days ago

MHRA Approves UK’s First Anti-PD-1 Monoclonal Antibody for Treatment of Aggressive Form of Lung Cancer

Summary by GOV.UK

As with all products, we will keep its safety under close review

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

GOV.UK

MHRA approves UK’s first anti-PD-1 monoclonal antibody for treatment of aggressive form of lung cancer

As with all products, we will keep its safety under close review

11 days ago·United Kingdom

Read Full Article

GeneOnline News

Pfizer Secures Global Licensing Agreement with 3SBio for PD-1 and VEGF Targeting Antibody SSGJ-707

Pfizer Inc. has announced an exclusive global licensing […] The post Pfizer Secures Global Licensing Agreement with 3SBio for PD-1 and VEGF Targeting Antibody SSGJ-707 first appeared on GeneOnline News. The post Pfizer Secures Global Licensing Agreement with 3SBio for PD-1 and VEGF Targeting Antibody SSGJ-707 appeared first on GeneOnline News.

11 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right